Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P....
-
Upload
george-webb -
Category
Documents
-
view
216 -
download
0
Transcript of Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P....
![Page 1: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/1.jpg)
From Access to Engagement: Measuring Retention in Outpatient HIV Clinical Care
Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH,and Thomas P. Giordano, M.D., M.P.H.Volume 24, Number 10, 2010AIDS PATIENT CARE and STDs
![Page 2: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/2.jpg)
Introduction
Access to care has long been recognized as a vital factor in promoting and sustaining healthengagement means the processes of linkage to care and retention in care
![Page 3: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/3.jpg)
Introduction
EngagementDelayed linkage and poor retention in outpatient HIV care → delayed receipt of antiretroviral medications, higher rates of viral load failure, and increased morbidity and mortalitypatients engaged in clinical care, better retention →
reduced risk transmission, viral load suppressionRetention in care is being recognized as a crucial step in maximizing patient outcomes
![Page 4: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/4.jpg)
Methods
We reviewed the available published literature and summarized findings of the most commonly used measures to ascertain retention in outpatient HIV medicalMeasures of retention in care – Studies have typically included only scheduled outpatient medical appointmentsHIV biomarkers have been used to measure linkage and retention in HIV care, acting as a surrogate for a completed visit
![Page 5: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/5.jpg)
Methods
![Page 6: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/6.jpg)
MethodsMissed visits
1, 4, 0, 1Appointment adherence
80%, 33%, 100%, 66%Visit constancy
100%, 50%, 75%, 25%Gaps in care
B, D had a gap of over 6 monthsHRSA HAB medical visits performance measure
A, B, and C had 2 visits, D not
![Page 7: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/7.jpg)
Discussion
![Page 8: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/8.jpg)
Discussion
The clinician’s perspectivemissed visits and gap in care as intuitive measures of retentionPatient’s patterns of missed visits are likely taken into account by providers in determining the time interval for a subsequent clinic visitstudies have shown these 2 measures associated with patient outcomes including clinical events and mortality.
![Page 9: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/9.jpg)
Discussion
The administrator’s perspectiveAppointment adherence and HRSA HAB may be preferable for administratorsallow for longitudinal tracking of retention in care and also for setting an overall clinic benchmark (e.g., >80%)inform local, regional and/or national planning and resource allocation
![Page 10: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/10.jpg)
Discussion
Researcher’s perspectiveThe missed visits measure has been widely used particularly for preliminary research and short-term observation periods.appointment adherence and visit constancy may be preferable for research purposes, particularly for longer observation periods
![Page 11: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/11.jpg)
Discussion
Requisite clinic visit datavisit constancy, gaps in care, and the HRSA HAB are calculated based on completed visits onlyonly ‘‘no show’’ visits have been included in the missed visit and appointment adherence, but there are issues related to the timing of cancelled visits worth noting
![Page 12: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/12.jpg)
Discussion
Impact of clinic scheduling practicesClinics with automatic rescheduling of missed visits may lead to artificially poor missed visit and appointment adherence resultsConsiderable variability exists among HIV clinics in the availability and approach to handling unscheduled or acute care visits
![Page 13: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/13.jpg)
Discussion
Computational issuesmissed visits and appointment adherence – simplestgaps and HRSA HAB – calculation of the time interval between completed visitsConstancy – the observation period of interest be divided into intervals of interest
![Page 14: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/14.jpg)
DiscussionSensitivity in capturing disease severity and stage of treatment
HRSA HAB, the gaps – insensitive in capturing retention as it relates to issues of disease severity and stage, and rather represents a minimum standard of retention in caremissed visit and appointment adherence – visit frequency reflects the disease severity and stage of treatment for each individual patientconstancy – the capacity to account for severity and stage of treatment through variation of the time interval
![Page 15: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/15.jpg)
Future Direction
With growing emphasis on ‘‘test and treat’’ approaches to HIV prevention, there is a clear need for additional engagement in HIV care researchfuture research should evaluate the impact of such visits and their inclusion in HIV retention measures on patient outcomes
![Page 16: Michael J. Mugavero, M.D., MHSc, Jessica A. Davila, Ph.D., Christa R. Nevin, MSPH, and Thomas P. Giordano, M.D., M.P.H. Volume 24, Number 10, 2010 AIDS.](https://reader036.fdocuments.net/reader036/viewer/2022082517/56649e7a5503460f94b7b405/html5/thumbnails/16.jpg)
Conclusion
This article provides a synthesis of the most commonly used measures of retention in HIV care, their methodological and conceptual strengths and limitations, and suggests situations in which certain measures may be preferred over others